Haloperidol Prodes (Haloperidol)

Haloperidol Prodes is indicated for several psychiatric disorders where dopamine blockade is beneficial. It is prescribed by healthcare professionals based on individual patient assessment.

• Treatment of schizophrenia, including maintenance therapy.
• Management of acute psychotic episodes.
• Control of manic episodes associated with bipolar disorder.
• Reduction of symptoms in Tourette syndrome.
• Adjunctive therapy for severe agitation or aggression.

Haloperidol Prodes may cause a range of side effects, varying in frequency and severity.

Common

• Drowsiness or sedation.
• Extrapyramidal symptoms such as tremor or rigidity.
• Dry mouth.
• Constipation.
• Blurred vision.
• Weight gain.

Serious

• Neuroleptic malignant syndrome.
• Tardive dyskinesia.
• Severe hypotension.
• Cardiac arrhythmias (QT prolongation).
• Hyperprolactinemia leading to hormonal disturbances.
• Severe allergic reactions (e.g., rash, angioedema).

Before initiating Haloperidol Prodes, clinicians should evaluate patient history and monitor for potential risks.

• Assess for cardiovascular disease, especially QT prolongation risk.
• Monitor for movement disorders, particularly with long‑term use.
• Use cautiously in patients with a history of seizures.
• Evaluate liver and kidney function periodically.
• Discuss potential pregnancy and lactation considerations with women of childbearing age.
• Educate patients about signs of neuroleptic malignant syndrome and advise immediate medical attention if they occur.

Haloperidol Prodes can interact with several medications, influencing its efficacy or safety profile.

Avoid

• Other dopamine antagonists or antipsychotics, which may increase extrapyramidal side effects.
• Medications that prolong the QT interval (e.g., certain antiarrhythmics, macrolide antibiotics).
• Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin) that can raise haloperidol plasma levels.

Use with caution

• CNS depressants such as benzodiazepines or opioids, which may enhance sedation.
• Anticholinergic agents, which can mask early signs of extrapyramidal symptoms.
• Antihypertensive drugs, as haloperidol may cause orthostatic hypotension.
• Lithium, due to potential additive neurotoxic effects.